BioCentury
ARTICLE | Financial News

Isis raises $171 million in follow-on

May 10, 2013 1:12 AM UTC

Antisense technology company Isis Pharmaceuticals Inc. (NASDAQ:ISIS) raised $171 million through the sale of 9 million shares at $19 million in a follow-on underwritten by Goldman Sachs; JPMorgan; Stifel Nicolaus Weisel; BMO Capital Markets; Cowen; and Needham. Isis proposed the offering late Tuesday, when its stock price was $21.89. On Thursday, Isis was down $1.16 to $18.49. ...